Peter Åsberg

Title: Peter Åsberg: Innovator in Pharmaceutical Chemistry

Introduction

Peter Åsberg is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of 3 patents. His work focuses on developing innovative solutions for therapeutic applications.

Latest Patents

Peter Åsberg's latest patents include groundbreaking inventions. One of his notable patents is for "Amorphous active pharmaceutical ingredients comprising substantially amorphous mesoporous magnesium carbonate." This invention involves a solid and substantially amorphous admixture that includes Sorafenib as the active pharmaceutical ingredient and a particulate anhydrous and substantially amorphous mesoporous magnesium carbonate. It also details a method for manufacturing this formulation and an oral pharmaceutical formulation comprising the solid substantially amorphous admixture.

Another significant patent is for "Substituted aromatic oligomers." This invention relates to novel chemical compounds that are useful in therapy, particularly for treating diseases involving misfolded or aggregated forms of proteins. The compounds are characterized by a specific formula and structural features that enhance their therapeutic potential.

Career Highlights

Throughout his career, Peter Åsberg has worked with various companies, including Neuroscios GmbH and Biochromix Newco AB. His experience in these organizations has contributed to his expertise in pharmaceutical innovations and research.

Collaborations

Peter has collaborated with several professionals in his field, including Kristin Hammer and Johan Olsson. These collaborations have likely enriched his research and development efforts.

Conclusion

Peter Åsberg is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable innovations. His patents reflect his commitment to advancing therapeutic solutions, making a significant impact in the industry.